AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly transferring manufacturing” across the Atlantic.
Related Posts
Some lawmakers in both parties question the legality of Trump’s Iran strikes
Many politicians raised constitutional concerns about Trump’s acting without approval by Congress. But some GOP leaders offered support for his move.
Abercrombie & Fitch soars 25% even as retailer slashes profit outlook due to tariffs
Abercrombie & Fitch’s growth is slowing at its namesake brand and the company is expecting tariffs to reduce its earnings by $50 million.
Judge delays key ruling on fate of Trump hush money conviction
A New York jury found Donald Trump guilty on 34 counts of falsifying business records related to a hush money payment to porn start Stormy […]